Partners in lowering cholesterol: Comparison of a multidisdplinary educational program, monetary incentives, or usual care in the treatment of dyslipidemia identified among employees

被引:18
作者
Bloch, Michael J.
Armstrong, David S.
Dettling, Lisa
Hardy, Aaron
Caterino, Karen
Barrie, Sandie
机构
[1] St Marys Reg Med Ctr, Risk Reduct Ctr, Reno, NV 89511 USA
[2] Univ Nevada, Sch Med, Dept Med, Reno, NV 89557 USA
[3] Boehringer Ingelheim Pharmaceut Inc, Ingelheim, Germany
[4] Washoe Cty Sch Dist, Reno, NV USA
[5] Nevada Hlth Care Coalit, Reno, NV USA
关键词
D O I
10.1097/01.jom.0000205997.18143.6c
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective: We sought to assess whether either a low-cost educational intervention or small monetary incentive is more effective than usual care in lowering low-density lipoprotein (LDL) cholesterol among employees. Methods: Employees with an LDL-C > 130 mg/dL were eligible. After receiving on-line educational materials, subjects were assigned to three groups: group? I received S100 if they reduced their LDL-C by 15% within 6 months, group 2 participated in a multi-disciplinary educatioual program, and group 3 received no further intervention. Results: In total. 171 employees participated. Baseline mean LDL-C was 156 mg/dL. Approximately 6 months after randomization, mean LDL-C was reduced 17.9 mg/dL (11.3%) in group 1, 17.9 mg/dl, (11.5%) in group 2 and 5.5 mg/dL (3.5%) in group 3. Reductions in groups I and 2 were statistically superior to group 3 (P = 0.02). Conclusions: Both an employer directed low-cost educational program and small monetary incentives similarly lowered LDL-C compared with usual care.
引用
收藏
页码:675 / 681
页数:7
相关论文
共 32 条
[1]   Impact of the Coronary Health Improvement Project (CHIP) on several employee populations [J].
Aldana, SG ;
Greenlaw, R ;
Diehl, HA ;
Englert, H ;
Jackson, R .
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2002, 44 (09) :831-839
[2]   An experimental examination of the initial weeks of abstinence in cigarette smokers [J].
Alessi, SM ;
Badger, GJ ;
Higgins, ST .
EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY, 2004, 12 (04) :276-287
[3]  
[Anonymous], 2000, HLTH PEOPL 2010, V2nd
[4]   EPIDEMIOLOGY OF CORONARY HEART-DISEASE - THE FRAMINGHAM-STUDY [J].
CASTELLI, WP .
AMERICAN JOURNAL OF MEDICINE, 1984, 76 (2A) :4-12
[5]   Acarbose for prevention of type 2 diabetes mellitus: the STOPNIDDM randomised trial [J].
Chiasson, JL ;
Josse, RG ;
Gomis, R ;
Hanefeld, M ;
Karasik, A ;
Laakso, M .
LANCET, 2002, 359 (9323) :2072-2077
[6]   Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance - The STOP-NIDDM Ttrial [J].
Chiasson, JL ;
Josse, RG ;
Gomis, R ;
Hanefeld, M ;
Karasik, A ;
Laakso, M .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (04) :486-494
[7]  
Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3
[8]   Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels - Results of AFCAPS/TexCAPS [J].
Downs, JR ;
Clearfield, M ;
Weis, S ;
Whitney, E ;
Shapiro, DR ;
Beere, PA ;
Langendorfer, A ;
Stein, EA ;
Kruyer, W ;
Gotto, AM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (20) :1615-1622
[9]   A RANDOMIZED TRIAL OF THE IMPACT WORKSITE CHOLESTEROL REDUCTION PROGRAM [J].
FIELDING, JE ;
MASON, T ;
KNIGHT, K ;
KLESGES, R ;
PELLETIER, KR .
AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 1995, 11 (02) :120-123
[10]   NICOTINE GUM AND SELF-HELP BEHAVIORAL TREATMENT FOR SMOKING RELAPSE PREVENTION - RESULTS FROM A TRIAL USING POPULATION-BASED RECRUITMENT [J].
FORTMANN, SP ;
KILLEN, JD .
JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 1995, 63 (03) :460-468